Acrivon Therapeutics, Inc. ($ACRV)
Filing Information
| Accession Number | 0001231919-26-000686 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
20,275
Total Value
$0.00
P&L
+inf% (+$33,859.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (Right to Buy) | Derivative | Jun 17, 2026 | Grant/Award | 20,275 | $0.00 | $0.00 | 20,275 | Indirect | See Footnotes | View Details |